Replies to post #8472 on Revance Therapeutics Inc (RVNC)

[Tomdontworry]

What does Crown do with 70m shares at 6.55? File form 13D with the SEC within 5 days.

[iwfal]

They (Crown) already tried to buy the Korean alternative and it would be 4x’s the price.

Interesting (if true).

[RVNCfan]

I agree with your idea.
Korean toxin companies has been traded and acquired at a good price from global private equity fund in the M&A market i.e. Hugel.
Revance has to get much higher price in the M&A market. IMHO